Skip to Content

  • Search

View Additional Section Content

A Phase III Multicenter Randomized, Double-blind, Placebo-controlled, Parallel Group, Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN 115727) in Patients with Mild to Moderate Alzheimer''s Disease

Principal Investigator(s)
David Weisman, M.D.

Clinical Trial Categories

  • Neurology
Contact
Debi Murphy at 215-481-3627

Location

  • The Diamond Stroke Center at Abington Memorial Hospital

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a Test
Request an Appointment

215-481-EXAM

Clinical Trials Details